OP
TXG icon

ORG Partners’s 10x Genomics TXG Stock Holding History

ORG Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.39K Buy
+392
New +$5.92K ﹤0.01% 1147

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ORG Partners's TXG Position: Q4 2025 in Review

ORG Partners opened a new position in 10x Genomics (TXG) in Q4 2025: 392 shares worth $6.39K. The stake represents ﹤0.01% of the portfolio and ranks #1147 among its holdings.

322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • ORG Partners held 392 shares of 10x Genomics worth $6.39K as of Q4 2025.
  • 10x Genomics was a new ORG Partners position in Q4 2025.
  • 10x Genomics made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1147 holding.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.